Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report
Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report
SUMMARY
Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
KEY HIGHLIGHTS
Sanofi Genzyme (Genzyme or ‘the company), a specialty care global business unit of Sanofi provides treatments with a focus on rare diseases, multiple sclerosis, immunology, rare blood disorders and oncology. The major products of the company include Aldurazyme, Aubagio, Caprelsa tablets, Alprolix , Cablivi , Eloctate , Lumizyme ,LIBTAYO , Cerdelga capsules, Cerezyme, Clolar, Dupixent injection, Elitek, Eloxatin, Fabrazyme, Jevtana, Kevzara injection, Lemtrada, Lumizyme, , Taxotere injection concentrate, and ZALTRAP injection for intravenous infusion. The company also addresses the unmet needs in immune diseases including atopic dermatitis, rheumatoid arthritis, asthma, nasal polyposis, and eosinophilic esophagitis. The company primarily operates in the Americas and Europe. The company is headquartered in Cambridge, Massachusetts, the US.
SCOPE
SUMMARY
Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
KEY HIGHLIGHTS
Sanofi Genzyme (Genzyme or ‘the company), a specialty care global business unit of Sanofi provides treatments with a focus on rare diseases, multiple sclerosis, immunology, rare blood disorders and oncology. The major products of the company include Aldurazyme, Aubagio, Caprelsa tablets, Alprolix , Cablivi , Eloctate , Lumizyme ,LIBTAYO , Cerdelga capsules, Cerezyme, Clolar, Dupixent injection, Elitek, Eloxatin, Fabrazyme, Jevtana, Kevzara injection, Lemtrada, Lumizyme, , Taxotere injection concentrate, and ZALTRAP injection for intravenous infusion. The company also addresses the unmet needs in immune diseases including atopic dermatitis, rheumatoid arthritis, asthma, nasal polyposis, and eosinophilic esophagitis. The company primarily operates in the Americas and Europe. The company is headquartered in Cambridge, Massachusetts, the US.
SCOPE
- Detailed information on Sanofi Genzyme required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanofi Genzyme in the form of a SWOT analysis
- An in-depth view of the business model of Sanofi Genzyme including a breakdown and examination of key business segments
- Intelligence on Sanofi Genzyme's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanofi Genzyme, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Sanofi Genzyme and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sanofi Genzyme as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Sanofi Genzyme's business structure, strategy and prospects.
Company Snapshot
Sanofi Genzyme: Company Overview
Sanofi Genzyme: Overview and Key Facts
Sanofi Genzyme: Overview
Sanofi Genzyme: Key Facts
Sanofi Genzyme: Key Employees
Sanofi Genzyme: Key Employee Biographies
Sanofi Genzyme: Major Products and Services
Sanofi Genzyme: Company History
Sanofi Genzyme: Locations and Subsidiaries
Sanofi Genzyme: Key Competitors
Sanofi Genzyme: Company Analysis
Sanofi Genzyme: Business Description
Sanofi Genzyme: SWOT Analysis
Sanofi Genzyme: SWOT Overview
Sanofi Genzyme: Strengths
Sanofi Genzyme: Weaknesses
Sanofi Genzyme: Opportunities
Sanofi Genzyme: Threats
Sanofi Genzyme: Corporate Financial Deals Activity
Sanofi Genzyme: Financial Deals Overview
Sanofi Genzyme: Top Deals 2017 - 2021YTD*
Sanofi Genzyme: Partnership
Sanofi Genzyme: Divestments
Sanofi Genzyme: Recent Developments
Sanofi Genzyme: News and Events Summary
Sanofi Genzyme: Market Developments
Sanofi Genzyme: Regulatory and Legal Events
Sanofi Genzyme: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
Sanofi Genzyme: Company Overview
Sanofi Genzyme: Overview and Key Facts
Sanofi Genzyme: Overview
Sanofi Genzyme: Key Facts
Sanofi Genzyme: Key Employees
Sanofi Genzyme: Key Employee Biographies
Sanofi Genzyme: Major Products and Services
Sanofi Genzyme: Company History
Sanofi Genzyme: Locations and Subsidiaries
Sanofi Genzyme: Key Competitors
Sanofi Genzyme: Company Analysis
Sanofi Genzyme: Business Description
Sanofi Genzyme: SWOT Analysis
Sanofi Genzyme: SWOT Overview
Sanofi Genzyme: Strengths
Sanofi Genzyme: Weaknesses
Sanofi Genzyme: Opportunities
Sanofi Genzyme: Threats
Sanofi Genzyme: Corporate Financial Deals Activity
Sanofi Genzyme: Financial Deals Overview
Sanofi Genzyme: Top Deals 2017 - 2021YTD*
Sanofi Genzyme: Partnership
Sanofi Genzyme: Divestments
Sanofi Genzyme: Recent Developments
Sanofi Genzyme: News and Events Summary
Sanofi Genzyme: Market Developments
Sanofi Genzyme: Regulatory and Legal Events
Sanofi Genzyme: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
LIST OF TABLES
Table 1: Sanofi Genzyme: Key Facts
Table 2: Sanofi Genzyme: Key Employees
Table 3: Sanofi Genzyme: Company History
Table 4: Sanofi Genzyme: Locations and Subsidiaries
Table 5: Sanofi Genzyme: Key Competitors
Table 6: Sanofi Genzyme: Deal Activity by Deal Type - Volume (2017 - YTD*2021)
Table 7: Sanofi Genzyme: Top Deals 2017 - 2021YTD*
Table 8: Sanofi Genzyme: Partnership Volume and Value Trend (2017 - YTD*2021)
Table 9: Sanofi Genzyme: Partnership Trend by Deal Type (2017 - YTD*2021)
Table 10: Sanofi Genzyme: Divestments Volume and Value Trend (2017 - YTD*2021)
Table 11: Sanofi Genzyme: News and Events Summary
Table 12: Sanofi Genzyme: Market Developments
Table 13: Sanofi Genzyme: Regulatory and Legal Events
Table 14: Sanofi Genzyme: Research & Development
Table 1: Sanofi Genzyme: Key Facts
Table 2: Sanofi Genzyme: Key Employees
Table 3: Sanofi Genzyme: Company History
Table 4: Sanofi Genzyme: Locations and Subsidiaries
Table 5: Sanofi Genzyme: Key Competitors
Table 6: Sanofi Genzyme: Deal Activity by Deal Type - Volume (2017 - YTD*2021)
Table 7: Sanofi Genzyme: Top Deals 2017 - 2021YTD*
Table 8: Sanofi Genzyme: Partnership Volume and Value Trend (2017 - YTD*2021)
Table 9: Sanofi Genzyme: Partnership Trend by Deal Type (2017 - YTD*2021)
Table 10: Sanofi Genzyme: Divestments Volume and Value Trend (2017 - YTD*2021)
Table 11: Sanofi Genzyme: News and Events Summary
Table 12: Sanofi Genzyme: Market Developments
Table 13: Sanofi Genzyme: Regulatory and Legal Events
Table 14: Sanofi Genzyme: Research & Development
LIST OF FIGURES
Figure 1: Sanofi Genzyme: Deal Activity by Deal Type - Volume (2017 - YTD*2021)
Figure 2: Sanofi Genzyme: Partnership Volume and Value Trend (2017 - YTD*2021)
Figure 3: Sanofi Genzyme: Partnership Trend by Deal Type (2017 - YTD*2021)
Figure 4: Sanofi Genzyme: Divestments Volume and Value Trend (2017 - YTD*2021)
Figure 1: Sanofi Genzyme: Deal Activity by Deal Type - Volume (2017 - YTD*2021)
Figure 2: Sanofi Genzyme: Partnership Volume and Value Trend (2017 - YTD*2021)
Figure 3: Sanofi Genzyme: Partnership Trend by Deal Type (2017 - YTD*2021)
Figure 4: Sanofi Genzyme: Divestments Volume and Value Trend (2017 - YTD*2021)
